IceCure Medical (ICCM) Retained Earnings (2020 - 2026)

IceCure Medical (ICCM) has reported Retained Earnings for 7 consecutive years, with $141.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings rose 22.47% year-over-year to $141.1 million in Q2 2026; TTM through Jun 2026 was $141.1 million, a 22.47% increase from a year earlier, with the FY2025 full-year figure at $129.5 million, up 15.33% from the prior year.
• Retained Earnings was $141.1 million for Q2 2026 at IceCure Medical, up from $133.2 million in the prior quarter.
• Over five years, Retained Earnings peaked at $141.1 million in Q2 2026 and troughed at $85.8 million in Q1 2022.
• A 5-year average of $109.0 million and a median of $106.3 million in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings climbed 25.56% in 2022 and increased 1.38% in 2023, its largest moves.
• Over 5 years, Retained Earnings stood at $100.8 million in 2022, then climbed by 1.38% to $102.2 million in 2023, then advanced by 9.84% to $112.3 million in 2024, then advanced by 15.33% to $129.5 million in 2025, then gained by 8.97% to $141.1 million in 2026.
• The last three Retained Earnings figures came in at $141.1 million (Q2 2026), $133.2 million (Q1 2026), and $129.5 million (Q4 2025), per Business Quant data.